HIV prevention trials network (hptn) coordinating and operations center

Active Cooperative Agreement Awarded Last action

Award ID
UM1AI068619
Recipient
Awarding agency
Obligated
$929,818,351

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date 95% complete
Originally
Funding
  • $811,563,727.77 Federal
  • $118,254,622.89 Non-federal
Place of performance
Durham, NC 27701, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $18,569,992
Amendment $18,569,992
Amendment $480
Amendment $480
Amendment $480
Amendment $480
Amendment $168,742
Amendment $168,742
Amendment $220,812
Amendment $220,812
Amendment $220,812
Amendment $10,000
Amendment $10,000
Amendment $10,000
Amendment $10,000
Amendment $10,000
Amendment $10,000
Amendment $1,500,000
Amendment $19,500,000
Amendment $19,500,000
Amendment HIV prevention trials network leadership and operations center -$8,787,242
Amendment Covpn 3008 - multi-center, randomized, efficacy study of covid-19 mrna vaccine in regions with sars-COV-2 variants of concern - this proposal outlines the… -$1,007,764
Amendment -$8,787,242
Amendment HIV prevention trials network leadership and operations center -$8,787,242
Amendment Covpn 3008 - multi-center, randomized, efficacy study of covid-19 mrna vaccine in regions with sars-COV-2 variants of concern - this proposal outlines the… -$7,779,478
Amendment $9,802,411
Amendment $9,802,411
Amendment HIV prevention trials network leadership and operations center $9,802,411
Amendment Covpn 3008 - multi-center, randomized, efficacy study of covid-19 mrna vaccine in regions with sars-COV-2 variants of concern - this proposal outlines the… $9,802,411
Amendment $9,802,411
Amendment HIV prevention trials network leadership and operations center -$44,188,335
Amendment Covpn 3008 - multi-center, randomized, efficacy study of covid-19 mrna vaccine in regions with sars-COV-2 variants of concern - this proposal outlines the… -$44,188,335
Amendment Covpn 3501: ELI lilly (LY3819253) protocol funding -$44,188,335
Amendment -$44,188,335
Amendment -$44,188,335
Amendment -$44,188,335
Amendment $12,774,001
Amendment $1,500,000
Amendment HIV prevention trials network leadership and operations center $1,353,261
Amendment Covpn 3008 - multi-center, randomized, efficacy study of covid-19 mrna vaccine in regions with sars-COV-2 variants of concern - this proposal outlines the… $12,774,001
Amendment $12,774,001
Amendment HIV prevention trials network leadership and operations center $1,500,000
Amendment Covpn 3501: ELI lilly (LY3819253) protocol funding $12,774,001
Amendment HIV prevention trials network leadership and operations center -$1,213,038
Amendment Covpn 3501: ELI lilly (LY3819253) protocol funding -$1,213,038
Amendment LOC: HIV prevention trials network - description (provided by applicant): the mission of the HIV prevention trials network (hptn) is to conduct research… -$1,213,038
Amendment Covpn 3008 - multi-center, randomized, efficacy study of covid-19 mrna vaccine in regions with sars-COV-2 variants of concern - this proposal outlines the… -$1,213,038
Amendment HIV prevention trials network leadership and operations center -$1,213,038
Show 40 more

Latest 50 listed here. See the rest on GovTribe.

Subawards

Subrecipient Amount Awarded
Northwestern University The Scholars Program supports early-career investigators through mentorship and collaboration to advance research on preventing human immunodeficiency virus. $64,838
The Trustees Of The University Of Pennsylvania Funding is for multi-center trial of the Adolescent Medicine Trials Network for HIV Interventions and HIV Prevention Trials Network and is a Non-Investigational… $130,192
Vanderbilt University Medical Center Funding is for the Scholars Program for investigations to collaborate on the HIV Prevention Tial Network. $59,056
University Of Texas Health Science Center At Houston Funding is to support site development and activities for a Phase 1 clinical trial evaluating the safety drug levels and laboratory activity of… $53,964
New York University Funding is to provide conducts multidisciplinary research on biomedical and behavioral strategies aimed at reducing HIV acquisition and transmission. $36,248
Emory University Funding is for HIV prevention research scholars program to conduct mentored research develop skills analyze study data present findings and prepare a… $60,000
University Of California, LOS Angeles Funding for multi-site clinical study evaluating whether doxycycline can prevent bacterial sexually transmitted infections in adolescent and young adult females… $130,192
The Trustees Of The University Of Pennsylvania Funding supports a Scholars program developed by the HIV Prevention Trials Network to support early-career investigators collaborating on HIV prevention… $60,000
Emory University Funding is for study to evaluate if doxycycline can reduce bacterial sexually transmitted infections among adolescent and young adult women. It compares… $130,192
The Trustees Of Columbia University In The City Of New York To evaluate the efficacy of doxycycline (both on-demand and weekly dosing separately) in reducing overall quarterly STI incidence of GC CT and early syphilis… $130,192
Florida State University The HIV Prevention Trials Network researches biomedical and behavioral HIV prevention strategies. Dr. Hightow-Weidman supports platform development and brings… $38,512
Wits Health Consortium (Pty) LTD Funding supports the scientific management financial and operational oversight of the HIV Prevention Trials Network which works to prevent HIV among populations… $287,578
The Johns Hopkins University Funding supports a Phase 2 open-label, multi-center, randomized clinical trial comparing doxycycline with recommended penicillin treatment for neurosyphilis. $59,760
Mu-Jhu Care LTD Funding supports the HIV Prevention Trials Network Scholars Program supports early career investigators from underrepresented groups through mentorship and… $46,627
University Of Cape Town Provide study-specific development and implementation cost support to the University of Cape Town Clinical Trials Unit and Groote Schuur HIV Clinical Research… $89,475
Faculty Of Medicine And Health Sciences University Of Zimbabwe Funding supports the HIV Prevention Trials Network Scholars Program supports early career investigators from underrepresented groups through mentorship and… $49,030
Florida International University $54,737
University Of Illinois The purrpose of this subaward is to provide study-specific development and impleentation cost supoort to participate in the Bexsero clinical trial. $600,000
University Of North Carolina At Chapel Hill Funding is to support HIV Prevention Trials Network 112 study. $752,833
University Of North Carolina At Chapel Hill Funding is to support Phase 1 clinical trial evaluating the safety tolerability and pharmacokinetics of monoclonal antibodies in adults without HIV including… $60,437
Yale Univ Funding supports implementation and coordination of the Culturally Responsive Intersectional Stigma Prevention and Health Equity interventions for an HIV… $8,298,171
The Johns Hopkins University Funding is to support a Phase 2 clinical trial evaluating the safety acceptability and drug levels of twice-yearly lenacapavir for HIV prevention in 250 adult… $217,809
The Trustees Of Columbia University In The City Of New York Funding to evaluate a single dual prevention pill combining HIV prevention medication and oral contraception compared with a two-pill regimen for HIV prevention… $57,609
Rutgers, The State University Funding support to provide scientific leadership during the development implementation and reporting of the study and to assume responsibility for completion of… $117,557
Magee-Womens Research Institute And Foundation Funding supports clinical research on the safety effectiveness use and acceptance of products designed to prevent HIV. The goal is to develop safe effective… $13,559,671
Fenway Community Health Center, Inc. Funding support for the development oversight and coordination of the Extension of Community Health Outcomes component of the Culturally Responsive… $529,028
The Regents Of The University Of California. San Francisco Funding is for study-specific support for the University of Zimbabwe Clinical Trials Unit and five clinical research sites to conduct and manage all… $3,945,850
University Of Texas Health Science Center At Houston Funding is to reduce human immunodeficiency virus infections among men who have sex with men in the Southern United States by increasing testing preventive… $48,803
President And Fellows Of Harvard College Funding for HIV PREVENTION TRIALS NETWORK to carry out activities related to 084 study $599,894
University Of California, LOS Angeles Funding is to support HPTN 094 study development implementation and pre-implementation activities. $547,582
The Trustees Of Columbia University In The City Of New York The HIV Prevention Trials Network conducts collaborative multi-site research on biomedical and behavioral strategies to prevent HIV acquisition and transmission… $231,544
Makerere University School Of Public Health Funding is to prevent HIV among at-risk populations through an expanding network of clinical research sites. $104,768
University Of Rochester Funding is to support a study evaluation that integrades approach to reduce Human Immunodeficiency Virus infections among men who have sex with men in the… $845,855
University Of Cape Town Funding supports the University of Cape Town and Emavundleni Clinical Research Site in South Africa to conduct an HIV prevention study evaluating injectable and… $567,474
Stellenbosch University Stellenbosch University Clinical Trials Unit and the Desmond Tutu Tuberculosis Centre clinical research site in South Africa are to conduct and manage a… $592,332
South African Medical Research Council Funding is to provide study-specific site cost support for the Phase 3 Double Blind Safety and Efficacy Study of Long-Acting Injectable Cabotegravir Compared to… $1,133,554
The Trustees Of Columbia University In The City Of New York To carry out Phase 3 double-blind study of the safety and efficacy of long-acting injectable cabotegravir vs. daily oral TDF/FTC for HIV pre-exposure… $3,262,952
Wits Health Consortium (Pty) LTD Funding is to support the HPTN 084 Phase 3 randomized double-blind trial evaluating long-acting injectable cabotegravir versus daily oral tenofovir disoproxil… $541,731
Wits Health Consortium (Pty) LTD Funding supports a Phase 3 study comparing the safety and effectiveness of long-acting injectable cabotegravir with daily oral medication to prevent HIV in… $516,906
Asociacion Civil Impacta Salud Y Educacion Funding supports site development and management activities for participation in a clinical research study evaluating methods for preventing HIV infection. $1,147,810
Show all 40

Quick answers

Who received award UM1AI068619?

UM1AI068619 was awarded to Family Health International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2006.

How much is award UM1AI068619 worth?

$929,818,351 has been obligated on UM1AI068619: $811,563,728 in federal funding and $118,254,623 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login